Tag: pharmaceuticals
-
Cannabidiol Drug Maker Acquired in $7.2B Deal
A developer of treatments for rare neurological diseases derived from cannabis is being acquired by Jazz Pharmaceuticals in a $7.2 billion deal.
-
One-Dose Covid-19 Vaccine Shown to Prevent Hospitalization
Results from four international clinical trials show high disease prevention rates from one dose of the Oxford-AstraZeneca Covid-19 vaccine.
-
Covid-19 Vaccine Shown Safe, Effective in Russian Test
Interim results from a clinical trial in Russia of a two-dose vaccine show a high efficacy rate in preventing Covid-19 disease and few serious adverse effects.
-
Cancer Immunotherapy Adapted for HIV
A biotechnology company is adapting and licensing its immunotherapy process, originally designed for cancer, as a cure for HIV infections.
-
Infographic – More Eager for Covid-19 Vaccine
Surveys by the polling company Ipsos indicate publics in 15 countries overall are more willing than before to get vaccinated against Covid-19 disease.
-
Novavax, J&J Return Mixed Covid-19 Vaccine Results
Results from international clinical trials show largely favorable results for two Covid-19 vaccines, but still limitations against the South African variant.
-
Investors Raise $1.85B for Biotech Start-Ups
A venture capital company investing in life science and health care businesses raised $1.85 billion to finance biotechnology start-ups.
-
Trial Testing Multi-Company Covid-19 Therapy
A clinical trial already underway is expanding to test a combination of two synthetic antibodies from different companies as a treatment for Covid-19 infections.
-
Food Allergy Biotech Raises $40M in New Funds
A biotechnology company designing proteins in food products and therapies for people with food allergies is raising $40 million in its second venture round.
-
Antibody Therapy Shown to Prevent Covid-19 Disease
Clinical trial results show a combination of synthetic antibodies designed to treat Covid-19 infections can also prevent contracting the disease.